Enliven Therapeutics, Inc. (ELVN)
NASDAQ·Healthcare·Biotechnology
$52.98
-1.45%
Mkt Cap $3.77B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (12 analysts)
$69.20
Range $59.00 – $80.00
Implied Upside
+30.6%
Consensus $69.20 vs current $52.98
NASDAQ·Healthcare·Biotechnology
$52.98
-1.45%
Mkt Cap $3.77B
Buy
8
Hold
0
Sell
0
Price Target (12 analysts)
$69.20
Range $59.00 – $80.00
+30.6%
Consensus $69.20 vs current $52.98